This research study is conducted for Evofem, Inc. and the name of this investigational product is EVO100 vaginal gel. EVO100 vaginal gel is a single-dose, pre-filled applicator designed to maintain the normal, low pH of the vagina. A lower vaginal pH may prevent sexually transmitted infections (STIs), including Chlamydia trachomatis (CT) infection and Neisseria gonorrhoeae (GC) infection. Your total length of participation in this study is expected to be approximately 25 weeks.
Qualified Participants must be:
· 18 YEARS OR OLDER
· SEXUALLY ACTIVE
· HAVE HAD CHLAMYDIA OR GONORRHEA INFECTION WITHIN 16 WEEKS
· CURRENTLY USING CONTRACEPTION